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Objective: Mineralization has been observed in osteoarthritic cartilage but the mechanisms are incom-
pletely understood. Vitamin K is an essential cofactor in post-translational modiﬁcation of proteins
where speciﬁc Glu residues become modiﬁed to Caþþ binding g-carboxyglutamic acid residues (Gla). One
such protein, matrix Gla protein (MGP), is a known mineralization inhibitor. This study determined if
synthesis of MGP and formation of a fetuineMGP protein complex was altered in chondrocytes and
vesicles from osteoarthritis (OA) cartilage.
Methods: Chondrocytes and vesicles were isolated from normal and OA human articular cartilage and
lysates prepared. Speciﬁc antibodies were used in immunoblotting to detect the mature fully
g-carboxylated form of MGP (cMGP) and non-g-carboxylated MGP (ucMGP) as well as fetuin and
MGPefetuin complexes. g-carboxylase activity was measured by 14CO2 incorporation into the carbox-
ylase peptide substrate FLEEL. Immunocytochemistry was used to examine fetuin in cartilage sections
and uptake of biotin-labeled fetuin by isolated chondrocytes.
Results: Chondrocytes and vesicles from osteoarthritic tissue produced signiﬁcantly less cMGP compared
to those from normal cartilage. This correlated with signiﬁcantly less vitamin K-dependent g-carboxylase
enzyme activity in OA chondrocytes. Fetuin was found to be present in articular cartilage and cultured
chondrocytes were capable of fetuin uptake. A fetuineMGP complex was identiﬁed in normal chon-
drocytes and in vesicles shed from these cells but not in OA cells or vesicles.
Conclusions: The absence of cMGP and of the cMGPefetuin complex in OA cells and OA vesicles may be an
important mechanism for increased mineralization of osteoarthritic cartilage.
 2010 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
Osteoarthritis (OA) is characterized by a progressive loss of
articular cartilage accompanied by new bone formation and often
synovial proliferation that culminates in pain, loss of joint function,
and disability. During the development of OA, articular chon-
drocytes can assume the hypertrophic phenotype that is charac-
teristic of the mineralizing region of the growth plate1,2.
Chondrocyte hypertrophy in OA is commonly associated with
mineralization in the cartilage matrix3. Crystal formation and
abnormal mineralization in the articular cartilage may contribute
to the progression of OA4.Richard F. Loeser, Molecular
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s Research Society International. PIt is now well established that vitamin K is essential in
prevention of soft tissue mineralization5e7. In the classical experi-
ment carried out by Luo et al.7, where the vitamin K-dependent
protein matrix Gla protein (MGP) was deleted, mice developed
severe calciﬁcation of cartilage and the arterial wall with death as
an early endpoint. Vitamin K is an essential cofactor in post-
translational modiﬁcation of a family of proteins where speciﬁc Glu
residues in the protein sequence become modiﬁed to Caþþ binding
g-carboxyglutamic acid residues (Gla)8. This modiﬁcation of coag-
ulation factors made in the liver is essential for normal hemostasis.
We have shown previously that chondrocytes synthesize MGP and
possess an active post-translational g-carboxylation system9,10.
There is also evidence that MGP binds bone morphogenetic
proteins-2 and -4 (BMPs-2 and BMPs-4) which prevents these
growth factors from transforming cells into bone forming cells11e13.
Since the pathological transformation of normal chondrocytes
into OA chondrocytes involves chondrocyte hypertrophy andublished by Elsevier Ltd. All rights reserved.
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is accompanied by a loss of vitamin K function and altered
biosynthesis of the vitamin K modiﬁed calciﬁcation inhibitory
protein MGP. Altered MGP function could also allow for an increase
in the local activity of BMPs which could promote osteophyte
formation. Indeed, one epidemiologic study has shown a correla-
tion between low plasma levels of phylloquinone (primary plasma
form of vitamin K) and the presence of osteophytes on knee
radiographs14. The objective of the present study was to determine
if chondrocytes from OA cartilage, when compared to cells isolated
from normal cartilage, had altered production of the mature, fully
g-carboxylated MGP.
In order to investigate the calciﬁcation inhibitory property of
MGP as it works in vivo, it is necessary to combine such studies with
studies on fetuin which can bind the mature fully-g -carboxylated
form ofMGP15. The blood born protein a-fetuin (fetuin), also known
as a2-HermanseSchmid Glycoprotein is synthesized in the liver
and accumulates in high concentration in bone16e18. Fetuin has
been shown to bindmature MGP but not to the un- or incompletely
g-carboxylated MGP17. The way the fetuineMGP complex works as
an anti-calciﬁcation inhibitory system is not completely under-
stood but it is likely that the complex is a needed carrier of the
highly insoluble protein MGP. We19 and others20 have shown that
fetuin is taken up by vascular smooth muscle cells (VSMCs) by an
unknown uptake mechanism and fetuin may have an intra-cellular
function as a carrier of MGP. It has been shown that both MGP and
fetuin are present in vesicles shed by VSMCs20. The complex may
initially be packed into intra-cellular lipid vesicles as suggested by
Reynolds et al.20,21. In the present study, extracellular vesicles from
normal and osteoarthritic chondrocytes were isolated to search for
the fetuineMGP complex shed by the cells. As shown by our data,
the complex is present in vesicles from normal but not in vesicles
from OA chondrocytes which supports the hypothesis of the exis-
tence of an enhanced calciﬁcation environment in osteoarthritic
lesions and suggests that vitamin K deﬁciency may contribute to
abnormal mineralization in OA.
Materials and methods
Materials
The human cMGP and ucMGP monoclonal peptide antibodies
were directed against residues 35e54 in the human Gla region of
the MGP sequence22. The cMGP antibody is conformation speciﬁc
and only recognizes fully g-carboxylated MGP when Caþþ binds to
the Gla residues22,23. The human ucMGP monoclonal peptide
antibody is directed against the same epitope (residues 35e54) of
the MGP sequence, though with the Glu residues in the peptide
used for antibody production and not Gla residues. Thus the ucMGP
antibody recognizes only non- or partially g-carboxylated MGP
(antibodies provided by Vascular Products, Maastricht,
Netherlands). The N-terminal human MGP polyclonal rabbit
peptide antibody (residues 23e53) was made by Alpha Diagnostic
International (San Antonio, TX). The antibody made against this
synthetic peptide recognizes human MGP independently of its g-
carboxylation modiﬁcation23. The antibody was afﬁnity puriﬁed by
our laboratory as described23. Sepharoseeprotein-A/G beads were
purchased from Sigma (St.Louis, MO). EZ-Link sulfosuccinimidyl 6-
(biotinamido)hexanoate and biotin were from Pierce (Rockford, IL).
Mouse monoclonal IgG anti-human fetuin-A (H-4): sc-133146 was
from Santa Cruz Biotechnology Inc. (Santa Cruz, CA). Afﬁnity puri-
ﬁed goat anti-human fetuin polyclonal antibodies were from R&D
Systems, Inc. (Minneapolis, MN). Mouse anti-biotin IgG, horse-
radish peroxidase-conjugated goat anti-mouse IgG, horseradish
peroxidase-conjugated rabbit anti-goat IgG, and rhodamine-labeled donkey anti-mouse IgG were from Jackson Immuno
Research Laboratories, Inc. (West Grove, PA).
Chondrocyte isolation and culture
Normal human ankle and knee articular cartilage was obtained
from tissue donors within 48 h of death through the National
Disease Research Interchange (Philadelphia, PA) or through the Gift
of Hope Organ and Tissue Donor Network (Elmhurst, IL) in accor-
dance with institutional protocol. Each donor specimenwas graded
for degenerative changes based on the ﬁve-point Collins scale, as
modiﬁed by Muehleman et al.24. Osteoarthritic cartilage was
discarded tissue obtained after knee replacement surgery for
a diagnosis of OA. Cartilage was dissected from the joints and
digested in a sequential manner with pronase and then overnight
with collagenase as previously described25. Viability of isolated
cells was determined using trypan blue and cells were counted
using a hemocytometer. Monolayer cultures were established by
plating cells in 10 cm or six-well plates at 2106 cells/ml in
Dulbecco’s Modiﬁed Eagle’s Medium (DMEM)/F-12 medium sup-
plemented with 10% FBS. Plates weremaintained for approximately
5e7 days with feedings every 2 days until they reached 100%
conﬂuency prior to experimental use. Cells were not passaged. For
experiments with cells in serum-free medium, the attached cells
were washed with phosphate buffered saline (PBS) before the
DMEM/F-12 mediumwithout serumwas added. Depending on the
experimental plan, cells were cultured for 24 or 48 h in serum-free
medium. Fresh serum-free medium was added after 24 h.
Preparation of vesicles from normal and osteoarthritic chondrocytes
The procedure used for isolation of chondrocyte shed vesicles
was adapted from the work published by Reynolds et al.21 in their
effort to isolate vesicles fromculturedVSMCs. Collagenase treatment
of the cultures was not carried out prior to removing the cells from
the dishes. Conﬂuent chondrocytes cultured either for 24 or 48 h in
serum-freemediumwerewashed twicewith PBS and removed from
the 10 cm culture dish with a cell scraper. The cell suspension was
centrifuged at 2500 rpm in an Eppendorf Centrifuge 5810R centri-
fuge in order to remove cells and cell debris. The supernatant was
carefully removed and subjected to centrifugation at 100,000g for
45 min in a Beckman L8-M Ultracentrifuge at 4C. The pelleted
vesicles were stored frozen at85C until used for the experiments.
Electron microscopy
Vesicles were resuspended in 2.5% glutaraldehyde bufferedwith
0.1 M phosphate buffer pH 7.3. The sample was post ﬁxed with 1%
osmium tetroxide in 0.1 M phosphate buffer for 1 h. Subsequently,
the sample was dehydrated and embedded in Spurr’s resin and
cured overnight in a 60C. Eighty nm sections were cut with an
ultramicrotome, stained with uranyl acetate and lead citrate, and
viewed with a Philips 400 TEM.
Alkaline phosphatase activity measurements
Vesicles were resuspended in PBS and washed two times with
PBS followed by re-pelleting by centrifugation at 100,000g. The
washed pellets were lysed on ice for 30 min in 100 ml of 0.1 M
glycine buffer, pH 9.6 containing 1% NP-40, 1 mM MgCl2, 1 mM
ZnCl2. After lysis, the samples and 100 ml of the alkaline phospha-
tase substrate solution included in the alkaline phosphatase kit
(Bio-Rad, Herculus, CA) were added to wells on microtiter plates
and incubated for 15 min at 37C. After incubation, the reactionwas
stopped by adding NaOH and the optical density read at 405 nM to
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enzyme activity was measured as nmol product produced per min
and mg of protein.
Immunoprecipitation, one-dimensional-SDS-PAGE, and
Western blotting
Cellswere lysed on ice for 30 min in 50 mMTris,1%Nonidet P-40,
0.25% sodium-deoxycholate, 150 mM NaCl, 1 mM ethyl-
enediaminetetraacetic acid (EDTA), pH 7.2, containing 10 mg/ml of
the Sigma protease inhibitor mixture for use with mammalian cell
and tissue extracts (RIPA buffer). After lysis, cell debris was removed
by centrifugation at 12,000g for 30 min, and the supernatant was
collected. Prior to immunoprecipitation, the supernatant was pre-
cleared byabsorbing itwith Sepharoseeprotein-A/G beads for 1 h at
4C. The beads were removed by centrifugation, and the superna-
tant was immunoprecipitated by adding either mouse monoclonal
anti-human fetuin antibody or afﬁnity puriﬁed goat anti-human
fetuin antibody. For control experiments, preimmunemouse or goat
IgGs were added to the respective samples. The antibody mixtures
were allowed to react on a rotating devise overnight at 4C. Then,
Sepharoseeprotein-A/G beads were added, and the mixture was
incubated for an additional 2 h at 4C. The beads were washed four
times in cold lysis buffer. For one-dimensional-SDS-PAGE, immune
complexes were released from the beads by boiling them in SDS-
PAGE buffer containing 5% mercaptoethanol (ME). Samples were
loaded onto 8e16% CRITERION SDS-PAGE gels (Bio-Rad, Richmond,
CA), and electrophoresed proteins transferred to polyvinylidene
ﬂuoride (PVDF) membranes for Western blotting. Total protein in
isolated vesicles fromnormal andOAchondrocytes,when separated
by one-dimensional-SDS-PAGE, were stained with a silver staining
kit purchased from Bio-Rad (Richmond, CA).
Two-dimensional (2-D)-SDS-PAGE
Cell proteins in RIPA buffer were precipitated with ice-cold
acetone and washed with trichloroacetic acid and ether/ethanol.
The ﬁnal dried protein precipitate was dissolved in the 8 M urea
containing isoelectric focusing (IEF) sample buffer 1 obtained from
Bio-Rad (Richmond, CA). Prior to IEF, insoluble material was
removed by centrifugation, and protein samples were absorbed
onto 11 cm agarose/plastic strips with immobilized ampholyte
gradients from pH 3 to 10 (Bio-Rad). IEF of the proteins was carried
out in a Bio-Rad PROTEAN II IEF apparatus according to the
supplier’s instructions and separated in the second dimension on
8e16% SDSCRITERIONgels. Transfer of the 2-D-SDS-PAGE separated
proteins to PVDF membranes for Western blotting was carried out
as described previously our laboratory19. For staining of the proteins
on the PVDFmembrane followingWestern blotting of the 2-D blots,
the membranes were washed brieﬂy in distilled water and stained
for 2 min in 50% ethanol, 10% acetic acid containing 0.2% Coomassie
Brilliant blue. When the stained membranes were dried, the
proteins appeared as blue spots against a white background. It was
found that this staining procedure could only be carried out if the
PVDF membrane had been blocked with fat-free milk powder.
Partial puriﬁcation of human bone MGP
Small pieces of human bone left over after removal of the carti-
lage were soaked in liquid nitrogen and crushed into a ﬁne powder
with a strong mortar. The powder was suspended in 10% triﬂuro-
acetic acid overnight at 4C and the unsolubilized bone removed by
ﬁltration and centrifugation. The supernatant was dialyzed exten-
sively against distilled water for 2 days and a precipitate of protein
sediment at the bottom of the dialysis bag. The sediment washarvested and lyophilized and stored at 20C for use as a crude
mixture of bone matrix proteins enriched in mature MGP.
g-Carboxylase activity
g-Carboxylase activity was assayed in 24 h cultured chon-
drocytes from normal (n¼ 2) and osteoarthritic tissues (n¼ 2) as
14CO2 incorporation into the synthetic g-carboxylase peptide
substrate FLEEL as described9. The reactionwas triggered by adding
chemically reduced vitamin K1H2 (100 mg/ml) to the assay mixture.
Pairs of normal and OA samples were tested at the same time and
each sample was measured in triplicate. The results were analyzed
by Student’s t-test using StatView software (SAS Institute, Cary, NC).
Biotin labeling of fetuin
Five mg of a2-hs-Glycoprotein (fetuin) isolated from human
plasma (Sigma, St.Louis MO, #G0S16) was dissolved in 0.5 ml of
PBS. A 20-fold molar excess of EZ-Link sulfosuccinimidobiotin was
added to the fetuin solution, and the mixture reacted for 30 min at
room temperature in the dark on a rotating shaker. The reaction
mixture was gel-ﬁltrated on Sephadex G-25 in PBS, and the void
volume fraction containing biotin-conjugated fetuin was collected.
The biotin-conjugated fetuin was dialyzed against PBS overnight at
4C and sterile-ﬁltrated before added to cell culture media.
Immunohistochemistry
Normal chondrocytes cultured in serum-free DMEM/F-12
medium were depleted of endogenous fetuin by incubating the
cells for 15 min at 37C in the serum-free medium as described by
Lorenzo et al.26. Fetuin binding to the chondrocyte membrane was
investigated by incubating depleted cells with biotin-labeled fetuin
(50 mg/ml) in the serum-free medium for 30 min at 4C26. Cells
were washed with ice-cold PBS and ﬁxed for 10 min in 4% para-
formaldehyde. For uptake studies, cells incubated for 30 min at 4C
in the presence of 5 mg/ml biotin-labeled fetuin were exposed to
serum-free medium at 37C for an additional 30 min before being
ﬁxed in paraformaldehyde26. For ﬂuorescent staining, ﬁxed cells
were incubated at room temperature for 30 min with biotin-
speciﬁc monoclonal antibodies (1:100 dilution), followed by incu-
bation with rhodamine-labeled donkey anti-mouse IgG (1:200
dilution) for 30 min at room temperature. Rhodamine epiﬂuor-
escence images were obtained using a Zeiss Axioskop equipped
with a digital camera and Axovision imaging software. Final images
were processed using Adobe Photoshop Version 7.0.1. Images of
rhodamine epiﬂuorescence were also obtained by confocal
microscopy. A Zeiss Model 510 laser scanning confocal microscope
equipped with a 40 water immersion objective was used. The
optical slice thickness was 2.1 mm for each image. Cryo-embedded
cartilage was purchased from the National Disease Research
Interchange. Microtome cut sections were rehydrated in PBS and
non-speciﬁc immuno-globulin binding sites blocked by treatment
for 20 minwith 5% donkey serum in PBSwith 0.5% Triton X-100. For
identiﬁcation of fetuin in chondrocytes in their lacunas, an anti-
human fetuin monoclonal antibody was used as the ﬁrst antibody
diluted in PBS/TX-100. Secondary antibodies were applied for 1 h.
The secondary antibody was rhodamine red X-conjugated donkey
anti-mouse IgG. Confocal images were again collected with the
Zeiss confocal laser scanning microscope (LSM 510).
Mass spectrometry
Identiﬁcation of MGP in the cell culture medium from normal
chondrocytes was carried out by the proteomic core laboratory at
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proteins in the vesicle pellet isolated from normal chondrocytes
identiﬁed MGP among the proteins present in the pellet. Identiﬁ-
cation was made on 100% sequence match with two unique
peptides (23% coverage) and a 1% false discovery rate.
Results
Carboxylation status of MGP produced by normal and osteoarthritic
chondrocytes
Extracts from both normal chondrocytes and OA chondrocytes
cultured for 24 h in serum-free medium containedMGP recognized
by the N-terminal MGP antibody that recognizes MGP independent
of its carboxylation status [Fig. 1(A)]. Two immunoreactive bands
were noted in these blots where the upper band was at the same
position as partially puriﬁed human MGP extracted from human
bone. When the chondrocyte extracts were immunoblotted with
the cMGP antibody the upper band present in normal chondrocyte
extracts was the predominant band with a much fainter band
detected in OA chondrocytes [Fig. 1(B)]. The lower band, which was
predominant in the OA extracts, reacted with the monoclonal
ucMGP antibody [Fig. 1(C)]. This separation of the mature cMGP
form and the inactive ucMGP was accomplished by separation of
the two forms of the proteins in an 8e16% CRITERION gradient gel.
A difference in the apparent molecular masses of the cMGP and the
ucMGP, when run on SDS-PAGE gels, has been observed earlier27.
From these experiments, we could conclude that both normal and
OA chondrocytes synthesize approximately the same amount of
total MGP protein (compare lanes NC and OA in panel A) but
synthesis of the mature MGP was signiﬁcantly reduced in the OA
cells. A faint band reacting with the anti-ucMGP antibody was seen
also in the extract from the normal cells (panel C, lane NC) andmost
likely represents newly synthesized precursors of MGP that have
not yet been g-carboxylated. To gain insight into the process of
g-carboxylation of proteins in normal and OA chondrocytes, we
tested g-carboxylase activity in both cell types cultured for 24 h in
serum-free medium. Speciﬁc g-carboxylase activity in normal
chondrocytes was some ﬁve-times higher than the activity
measured in OA chondrocytes. Normal chondrocytes had an
activity of 501013.4 cpm/mg protein (mean s.d.) compared to
OA chondrocytes at 1033 47.4 (mean difference 3977, 95% conﬁ-
dence interval (CI) 3827e4127, P< 0.0001). These data support the
Western blotting data demonstrating deﬁcient production of cMGP
in OA chondrocytes.
Ability of normal but not OA chondrocytes to produce an
MGPefetuin complex
MGP is a highly insoluble protein, which, during its biosynthesis,
follows the secretory pathway from the ER to the Golgi apparatus
to acquire its post-translational modiﬁcations which include
g-carboxylation and phosphorylation. As noted in the introduction,Fig. 1. Production of MGP by normal and OA chondrocytes. Proteins in RIPA buffer extracts
a polyclonal N-terminal human MGP peptide antibody which recognizes human MGP in
antibody which recognizes the mature fully g-carboxylated form of MGP in the presence o
human MGP. Equal amounts of total protein were added in each lane. Lane Bone in A contbinding of MGP to fetuin may facilitate its transport and/or exit
from the cell. We conﬁrmed the presence of fetuin in normal
chondrocyte extracts by its characteristic shape and location on
a Coomassie blue stained membrane [Fig. 2(A)] and its reaction
with an anti-fetuin antibody [Fig. 2(B)]. To ﬁnd out if a cMGPefe-
tuin complex exists in chondrocytes, we immunoprecipitated RIPA
buffer extracts of normal chondrocytes using a fetuin monoclonal
antibody and separated the proteins by 2-D-SDS-PAGE. Western
blotting with the anti-cMGP antibody revealed the characteristic
shape and location of the fetuin molecule19, as it shows up in 2-
D-SDS-PAGE gels [Fig. 2(C)]. The anti-fetuin immunoprecipitant
also contained cMGP and a non-speciﬁc reaction of the secondary
horseradish conjugated goat anti-mouse IgG with the heavy chain
of the mouse anti-fetuin IgG used to precipitate the fetuinecMGP
complex. Together these experiments provide strong evidence for
the existence of an intra-cellular fetuinecMGP complex. Consistent
with data obtained previously19, no ﬁndings of immune reactions
with the fetuin protein present in 2-D-SDS-PAGE gels were seen
when Western blotted with the anti-ucMGP antibody (data not
shown).
Having demonstrated that a fetuinecMGP complex is formed
intra-cellularly in normal chondrocytes, we next searched for the
complex in vesicles shed from either normal or OA chondrocytes.
We selected to use a vesicle isolation procedure which does not
include collagenase treatment to release vesicles from the cell
culture in order to examine the spontaneous production of vesicles
rather than those generated by collagenase. For this, we used
a modiﬁcation of the procedure described by Reynolds et al.21 in
their effort to isolate matrix vesicles fromVSMCs (seeMaterials and
methods). We analyzed the vesicles shed from OA chondrocytes
and found a mixture of sizes ranging from about 75 nM to 200 nM
[Fig. 3(A)]. The vesicles had the size and appearance of what
previous studies have called matrix vesicles21,28,29. We tested
a preparation of the vesicles for alkaline phosphatase activity and
measured a speciﬁc activity of 24614 nmol/min/mg of protein.
This level of activity was almost two-fold higher than the
12514 nmol/min/mg of protein reported using a similar assay
with matrix vesicles isolated from control chick growth plate
chondrocyte cultures reported by Kirsch et al.29 but much lower
than that reported for mineralizing matrix vesicles induced by
vitamin C/phosphate treated growth plate chondrocytes in the
same study. Because we did not test the calciﬁcation potential of
the vesicles, we refer to the particles isolated in the present study as
vesicles rather than authentic matrix vesicles.We identiﬁedMGP in
the vesicle fraction shed from normal chondrocytes by mass
spectrometry (see Materials and methods). The vesicles were
further analyzed by SDS-PAGE and silver staining which detected
a number of protein bands [Fig. 3(B)] in vesicles from normal and
OA cultures. Western blotting with the anti-cMGP antibody only
recognized cMGP in vesicles from normal chondrocytes [Fig. 3(C)]
while Western blotting for fetuin recognized fetuin in both normal
and OA vesicles [Fig. 3(D)]. The fetuin content appeared to be lower
in vesicles harvested after 48 h compared to those cultured for onlyfrom normal (NC) and osteoarthritic (OA) chondrocytes were Western blotted with (A)
dependently of its g-carboxylation status, (B) conformational speciﬁc cMGP peptide
f Caþþ, and (C) the ucMGP antibody which recognizes none or under-g-carboxylated
ains human MGP protein partially puriﬁed from bone.
Fig. 2. Presence of fetuin and a fetuineMGP complex in normal articular chondrocytes. Samples of cell lysates from normal articular chondrocytes were separated by 2-D gel
electrophoresis as described in the Materials and methods. (A) Coomassie blue staining and (B) Western blot of the proteins shown in panel A with the mouse monoclonal anti-
human fetuin antibodies. The characteristic shape of the stained fetuin is pointed out by an arrow in panel A and panel B shows that stained fetuin protein reacts with the anti-fetuin
antibody (arrow). (C) Western blot of fetuin immunoprecipitated with mouse monoclonal fetuin antibodies from an RIPA buffer extract of normal chondrocytes and developed with
mouse anti-cMGP antibody. The most heavy protein band labeled fetuinecMGP shows that the characteristically shaped fetuin molecule (arrows) reacts with the anti-cMGP
antibody. The anti-cMGP antibody also recognized free cMGP that was seen on the blot (arrows, cMGP). The heavy chain of the anti-fetuin antibodies used to immunoprecipitate
fetuin is recognized by the secondary monoclonal horseradish conjugated goat anti-mouse antibodies (labeled HIgG).
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massie blue stained PVDF membrane that was used for Western
blotting. Staining of the membrane following Western blotting
demonstrates very similar loading of proteins in the OA and normal
lanes. We conclude from these experiments that vesicles shed from
normal chondrocytes, but not from OA chondrocytes, contain fully
g-carboxylated MGP while both normal and OA vesicles contain
fetuin.Fig. 3. MGP and fetuin in vesicles from normal and OA chondrocytes. Vesicles from normal (N
isolated by centrifugation as described in Materials and methods. (A) Electron microscopic im
a distance of 300 nm. Two panels are shown in order to demonstrate the variety of vesicl
osteoarthritic (V-OA) cells. Equal amounts of total protein were loaded in each lane. (C)
conformational speciﬁc antibody recognizes only the mature fully g-carboxylated MGP in
proteins in vesicles isolated at 24 and 48 h from cultured cells, respectively, blotted with ant
and E. (F) Coomassie blue stained proteins on the PVDF membrane used for fetuin WesternTo provide evidence that fetuin and cMGP seen on the vesicle
blots in (Fig. 3) from normal chondrocytes were assembled as
a complex, we repeated the immunoprecipitation experiments,
with anti-fetuin antibody, that we had performedwith cell extracts.
The anti-cMGP antibody again identiﬁed the fetuineMGP complex
and also signiﬁcant amounts of free cMGP (Fig. 4). On the same blot,
the heavy chain of the goat anti-IgG used for immunoprecipitation
was not recognized by the secondary anti-mouse IgGs antibodies) and osteoarthritic (OA) serum-free cultures (24 or 48 h serum-free as indicated) were
ages of matrix vesicles isolated from OA chondrocyte cell cultures. The bars represent
es. (B) Silver stained proteins present in the vesicles (V) from normal (lane V-N) and
Western blots with the anti-cMGP antibody of the proteins shown in panel B. This
the matrix vesicles shed from normal chondrocytes. (D) and (E) Western blots of the
i-fetuin antibody. Equal amounts of total proteins were loaded in each lane in panels D
blotting shown in panel E.
Fig. 4. Presence of the cMGPefetuin complex in vesicles from normal chondrocytes. An
RIPA buffer extract of vesicles isolated from normal chondrocytes was immunoprecip-
itated with afﬁnity puriﬁed goat anti-human fetuin antibody. The immune-precipitated
proteins on SepharoseeProtein-A/G beads were separated in 2-D-SDS-PAGE gels and
Western blotted with the mouse monoclonal anti-cMGP antibody. The characteristic
shape of the fetuinecMGP complex was seen as the high molecular weight band
(arrows) and free cMGP was also seen (low molecular weight band).
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in chondrocytes cultured in serum-containing and serum-free
medium, we used immunocytochemistry to examine uncultured
cartilage sections for fetuin. Fetuin was seen in chondrocytes
present within the cartilage matrix (Fig. 5). Higher magniﬁcation
images revealed fetuin in particles distributed in the cytosolic part
of the cells which may be intra-cellular vesicles [Fig. 5(B)]. Linking
this ﬁnding to our earlier ﬁnding of MGP in intra-cellular vesicles in
chondrocytes by electron microscopy10, adds additional support to
our hypothesis that intra-cellular vesicles carry fetuinecMGP
complexes.
Finally, we provide evidence for an uptake mechanism of fetuin
by cultured chondrocytes. As shown in (Fig. 6), biotinylated fetuin
binds to the cell membrane of chondrocytes at 4C (panel A) and is
taken up by endocytosis to appear intra-cellularly (panel B), when
the temperature is raised to 37C. The mechanism of uptake is still
unknown, but the results parallel data from uptake studies of other
proteins when the same experimental design was used26.Discussion
These results demonstrate an important difference between
chondrocytes isolated from normal and OA cartilage that might
explain the increased propensity for matrix mineralization in OAFig. 5. Immunolocalization of fetuin in human articular cartilage. Sections from human kn
Materials and methods. The section was reacted with a highly speciﬁc monoclonal rat recom
complexes with a donkey rhodamine conjugated anti-mouse antibody. Panel A shows fetuin
details of the rhodamine stained spots.cartilage. Although both normal and OA chondrocytes produced the
mineralization inhibitory protein MGP, OA cells produced primarily
ucMGP while normal cells produced the functional cMGP. This was
likely due to reduced levels of g-carboxylase activity noted in OA
cells. In addition, we found that chondrocytes imported the MGP
binding protein fetuin by endocytosis and formed a fetuineMGP
complex. Although there was no apparent difference between
normal and OA cells in the content of fetuin present in vesicles shed
from the cells, only vesicles from normal cells contained the func-
tional g-carboxylated MGP. Fetuin, by itself, is a Caþþ phosphate
binding protein and an inhibitor of basic Caþþ phosphate crystal
formation16. Fetuin is synthesized by the liver and secreted into
blood30. In addition to being an important calcium phosphate
carrying protein in blood which prevents precipitation of calcium
phosphate salts20, it is also carried to the bone where it is found as
one of the most abundant noncollagenous proteins18. In bone,
fetuin is a strong binding protein of fully g-carboxylated MGP
which forms a complex with MGP that is carried from bone into
blood as a fetuineMGP complex15. Binding of the complex is
believed to be mediated through binding via calcium phosphate
that is attached to the complex. However the serum fetuineMGP
complex is isolated from serum in the presence of 60 mM EDTA17
which suggest that additional binding interactions between the
two proteins also are involved. These studies support our ﬁnding of
the fetuineMGP complex in 2-D-SDS-PAGE gels. Price et al.17
propose that the strong calciﬁcation inhibitory properties of the
fetuineMGP complex results from the fact that the complex has
two protein components with strong calcium phosphate binding
capacity.
In cartilage as in bone, the fetuineMGP complex is likely to bind
to nascent mineral nuclei thus preventing the growth of mineral.
Basic calcium phosphate crystals appear to be the predominant
form present in OA cartilage3. We propose that the complex formed
between fetuin and cMGP signiﬁcantly enhances the ability of these
proteins to inhibit crystal formation. Fetuin, in vesicles shed from
normal chondrocytes, could carry an additional strong calciﬁcation
inhibitor (cMGP) into the normal cartilage matrix and the
fetuinecMGP complex would be expected to enhance the anti-
calciﬁcation environment. These results are supported by data
published by Reynolds et al.21 on Caþþ phosphate crystal formation
in cell cultures of VSMCs that also shed vesicles. The authors found
that the vitamin K antagonist warfarin, when added to the cell
cultures, triggered Caþþ phosphate crystal formation. Warfarin
inhibits carboxylation and thus formation of cMGP. It is not known
if warfarin directly affects the function of fetuin. How insolubleee articular cartilage were processed for confocal microscopy as described in detail in
binant anti-human fetuin peptide antibody followed by visualization on the immune
to be present in several lacuna. Panel B is an enlarged image to examine intra-cellular
Fig. 6. Biotin-labeled fetuin binding and uptake by cultured human chondrocytes. Human chondrocytes were depleted of endogenous fetuin as described in Materials and methods
and incubated at 4 or 37C in serum-free medium containing biotin-labeled human fetuin. (A) Cells incubated with biotin-labeled human fetuin for 30 min at 4C. (B) Cells
incubated with biotin-labeled fetuin for 30 min at 4C, followed by incubation at 37C for an additional 30 min; (C) same experiment as in (B) except that unlabeled fetuin was used
in the incubations. Rhodamine epiﬂuorescence images were obtained using a Zeiss Axioskop equipped with a digital camera and Axovision imaging software as described in
Materials and methods.
R. Wallin et al. / Osteoarthritis and Cartilage 18 (2010) 1096e11031102cMGP leaves viable cells has never been understood in great detail.
Our results present new data consistent with a cellular mechanism
for the release of MGP. We present evidence for the existence of an
intra-cellular fetuinecMGP complex in normal chondrocytes that
could serve as a chaperone mechanism needed to carry the insol-
uble cMGP packed intra-cellularly in vesicles which are shed into
the extracellular matrix by exit of these vesicles from the cell
membrane. Previously, we had noted the presence of MGP in
vesicle like structures within chondrocytes and in the immediate
matrix10. We propose that cMGP, but not ucMGP binds to Caþþ
phosphate carrying intra-cellular fetuin and becomes embedded in
lipid covered vesicles possibly originating from the Golgi apparatus
membrane, a mechanism known to be involved in carrying
a variety of other proteins intra-cellularly31. Because we found the
complex in vesicles shed from normal, non-mineralizing, articular
cartilage and because we did not assess the mineralizing activity of
these vesicles, we did not refer to them as authentic matrix vesicles
but rather simply as “vesicles”.
Most studies on soft tissue calciﬁcation have been carried out on
the arterial vessel wall32 and blood borne fetuin has been shown to
be endocytosed by VSMCs in culture20. In this paper, we show for
the ﬁrst time that cartilage, a non-vascularized tissue, contains
fetuin. Results from experiments using confocal microscopy of
human cartilage tissue supported the cell culture data and provide
evidence to suggest that chondrocyte fetuin uptake is an ongoing in
vivo mechanism. Furthermore, we showed fetuin uptake by chon-
drocytes in cell culture by a mechanism which was found to be
similar to the mechanism of fetuin uptake by cultured VSMCs.
Based on our data and data published by other investigators20,21 it
appears that the mechanism of action of fetuin and cMGP at the
cellular level in various cells share many biochemical and cellular
similarities. Recent studies have suggested a link between low
vitamin K intake and mineralization in the blood vessel wall. The
majority of the work to date suggests that MGP is a primary
regulator of blood vessel mineralization and that increased blood
vessel mineralization may occur when MGP is not fully
carboxylated6,33e35. Further studies are indicated to determine if
similar mechanisms are at play in articular cartilage. Our results
and previous studies showing increased cartilage mineralization in
MGP knock-out mice7, and inhibition of cartilage mineralization by
MGP overexpression36 are consistent with an important regulatory
role for MGP in controlling matrix mineralization in cartilage.
Keutel Syndrome, which is characterized by abnormal mineraliza-
tion in multiple cartilages including the growth plate37, has been
found to be associated withmutations in MGP38. Although articular
cartilage mineralization per se has not been described in Keutel
Syndrome, the vast majority of the reports have been in children
and it is possible that abnormal articular cartilage mineralizationwould not appear until more advanced age. It is also possible that
other mineralization inhibitors can compensate for a congenital
lack of MGP in articular cartilage or that MGP is more important in
inhibiting pathological mineralization associated with OA. Addi-
tional studies are needed to demonstrate the ability of the
fetuinecMGP complex to inhibit mineralization induced by adult
articular chondrocytes and to determine if vitamin K supplemen-
tation might be useful for preventing abnormal cartilage mineral-
ization in older adults.
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